Your browser doesn't support javascript.
loading
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.
Tarantelli, Chiara; Zhang, Lu; Curti, Elisabetta; Gaudio, Eugenio; Spriano, Filippo; Priebe, Valdemar; Cascione, Luciano; Arribas, Alberto J; Zucca, Emanuele; Rossi, Davide; Stathis, Anastasios; Bertoni, Francesco.
Afiliación
  • Tarantelli C; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Zhang L; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Curti E; Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Gaudio E; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Spriano F; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Priebe V; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Cascione L; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Arribas AJ; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Zucca E; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Rossi D; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stathis A; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.
  • Bertoni F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Haematologica ; 104(7): e307-e309, 2019 07.
Article en En | MEDLINE | ID: mdl-30679329
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Linfoma de Células del Manto / Proliferación Celular / Sinergismo Farmacológico / Agammaglobulinemia Tirosina Quinasa Límite: Humans Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Linfoma de Células del Manto / Proliferación Celular / Sinergismo Farmacológico / Agammaglobulinemia Tirosina Quinasa Límite: Humans Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Suiza